Dr. Iwata on Final OS Results From the Phase 3 IMpassion130 Trial in TNBC
November 20th 2020Hiroji Iwata, MD, PhD, vice director and chief of Breast Oncology at Aichi Cancer Center Hospital, discusses final overall survival results from the phase 3 IMpassion130 trial in triple-negative breast cancer.
Read More